Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism Bcr-Abl inhibitors(Bcr-Abl tyrosine kinase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chronic Myelogenous Leukemia | Preclinical | KR | 17 Mar 2023 | |
Chronic Myelogenous Leukemia | Preclinical | EG | 17 Mar 2023 |